Brand Name
Dolobid
Generic Name
Diflunisal
View Brand Information FDA approval date: March 08, 2012
Classification: Nonsteroidal Anti-inflammatory Drug
Form: Tablet
What is Dolobid (Diflunisal)?
Carefully consider the potential benefits and risks of Dolobid and other treatment options before deciding to use Dolobid. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. Dolobid is indicated for acute or long-term use for symptomatic treatment of the following: Mild to moderate pain Osteoarthritis Rheumatoid arthritis.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment

